Literature DB >> 21104462

Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration.

Paola Sgadò1, Cristina Viaggi, Annalisa Pinna, Cristina Marrone, Francesca Vaglini, Silvia Pontis, Nicola Biagio Mercuri, Micaela Morelli, Giovanni Umberto Corsini.   

Abstract

In idiopathic Parkinson's disease, clinical symptoms do not emerge until consistent neurodegeneration has occurred. The late appearance of symptoms implies the existence of a relatively long preclinical period during which several disease-induced neurochemical changes take place to mask the existence of the disease and delay its clinical manifestations. The aim of this study was to examine the neurochemical, neurophysiological, and behavioral changes induced by the loss of nigrostriatal innervation in the En1+/-;En2-/- mouse, in the 10 months following degeneration, compared to En2 null mutant mice. Behavioral analysis (Pole-test, Beam-walking test, and Inverted grid test) and field potential recordings in the striatum indicated that loss of ~70% of nigrostriatal neurons produced no significant functional effects until 8 months of age, when En1+/-;En2-/- animals started to show frank motor deficits and electrophysiological alterations in corticostriatal plasticity. Similarly, alterations in dopamine homeostasis, dopamine turnover, and dopamine innervation were observed in aged animals compared to young En1+/-;En2-/- mice. These data suggests that in En1+/-;En2-/- mice nigrostriatal degeneration in the substantia nigra is functionally compensated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21104462     DOI: 10.1007/s12640-010-9232-9

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  36 in total

1.  Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion.

Authors:  K Matsuura; H Kabuto; H Makino; N Ogawa
Journal:  J Neurosci Methods       Date:  1997-04-25       Impact factor: 2.390

2.  Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons.

Authors:  Lavinia Albéri; Paola Sgadò; Horst H Simon
Journal:  Development       Date:  2004-06-02       Impact factor: 6.868

3.  Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone.

Authors:  Sheila M Fleming; Chunni Zhu; Pierre-Olivier Fernagut; Arpesh Mehta; Cheryl D DiCarlo; Ronald L Seaman; Marie-Françoise Chesselet
Journal:  Exp Neurol       Date:  2004-06       Impact factor: 5.330

4.  Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox.

Authors:  A L Joyner; K Herrup; B A Auerbach; C A Davis; J Rossant
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

5.  Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse.

Authors:  E Bezard; M Jaber; F Gonon; A Boireau; B Bloch; C E Gross
Journal:  Eur J Neurosci       Date:  2000-08       Impact factor: 3.386

6.  Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1.

Authors:  Laure Sonnier; Gwenaëlle Le Pen; Andreas Hartmann; Jean-Charles Bizot; Fabrice Trovero; Marie-Odile Krebs; Alain Prochiantz
Journal:  J Neurosci       Date:  2007-01-31       Impact factor: 6.167

7.  CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity.

Authors:  C Viaggi; F Vaglini; C Pardini; P Sgadò; A Caramelli; G U Corsini
Journal:  J Neural Transm Suppl       Date:  2007

8.  Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: an in vivo imaging study.

Authors:  Vesna Sossi; Katherine Dinelle; Geoffrey J Topping; James E Holden; Doris Doudet; Michael Schulzer; Thomas J Ruth; A Jon Stoessl; Raul de la Fuente-Fernandez
Journal:  J Neurochem       Date:  2009-01-22       Impact factor: 5.372

9.  Rate of cell death in parkinsonism indicates active neuropathological process.

Authors:  P L McGeer; S Itagaki; H Akiyama; E G McGeer
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

10.  Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease.

Authors:  D B Calne; J W Langston; W R Martin; A J Stoessl; T J Ruth; M J Adam; B D Pate; M Schulzer
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

View more
  7 in total

1.  Diffusion Kurtosis Imaging Detects Microstructural Alterations in Brain of α-Synuclein Overexpressing Transgenic Mouse Model of Parkinson's Disease: A Pilot Study.

Authors:  Amit Khairnar; Peter Latta; Eva Drazanova; Jana Ruda-Kucerova; Nikoletta Szabó; Anas Arab; Birgit Hutter-Paier; Daniel Havas; Manfred Windisch; Alexandra Sulcova; Zenon Starcuk; Irena Rektorova
Journal:  Neurotox Res       Date:  2015-07-08       Impact factor: 3.911

2.  Sensorimotor behavioral tests for use in a juvenile rat model of traumatic brain injury: assessment of sex differences.

Authors:  Kristin L Russell; Katrina M Kutchko; Stephen C Fowler; Nancy E J Berman; Beth Levant
Journal:  J Neurosci Methods       Date:  2011-05-11       Impact factor: 2.390

Review 3.  Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.

Authors:  Jesse V Veenvliet; Marten P Smidt
Journal:  Cell Mol Life Sci       Date:  2014-07-27       Impact factor: 9.261

4.  Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinson's Disease.

Authors:  Anas Arab; Jana Ruda-Kucerova; Alzbeta Minsterova; Eva Drazanova; Nikoletta Szabó; Zenon Starcuk; Irena Rektorova; Amit Khairnar
Journal:  Neurotox Res       Date:  2019-06-18       Impact factor: 3.911

5.  A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats.

Authors:  Silke Nuber; Florian Harmuth; Zacharias Kohl; Anthony Adame; Margaritha Trejo; Kai Schönig; Frank Zimmermann; Claudia Bauer; Nicolas Casadei; Christiane Giel; Carsten Calaminus; Bernd J Pichler; Poul H Jensen; Christian P Müller; Davide Amato; Johannes Kornhuber; Peter Teismann; Hodaka Yamakado; Ryosuke Takahashi; Juergen Winkler; Eliezer Masliah; Olaf Riess
Journal:  Brain       Date:  2013-02       Impact factor: 13.501

6.  TRPV4 contributes to ER stress and inflammation: implications for Parkinson's disease.

Authors:  Na Liu; Liping Bai; Zhipeng Lu; Rou Gu; Dongdong Zhao; Fang Yan; Jie Bai
Journal:  J Neuroinflammation       Date:  2022-01-29       Impact factor: 8.322

7.  Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion.

Authors:  Lisette Blanco-Lezcano; Esteban Alberti-Amador; Mei-Li Díaz-Hung; María Elena González-Fraguela; Bárbara Estupiñán-Díaz; Teresa Serrano-Sánchez; Liliana Francis-Turner; Javier Jiménez-Martín; Yamilé Vega-Hurtado; Isabel Fernández-Jiménez
Journal:  Behav Sci (Basel)       Date:  2018-02-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.